Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-219-8 | CAS number: 634-93-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013-12-13 to 2014-06-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: the study was conducted under GLP and according to OECD 471 (1997), EPA OPPTS 870.5100 (1998) and EC 440/2008 B.13/14 (2008) without deviations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,4,6-trichloroaniline
- EC Number:
- 211-219-8
- EC Name:
- 2,4,6-trichloroaniline
- Cas Number:
- 634-93-5
- Molecular formula:
- C6H4Cl3N
- IUPAC Name:
- 2,4,6-trichloroaniline
- Test material form:
- not specified
- Details on test material:
- - Storage condition of test material: Stored at room temperature
Constituent 1
Method
- Target gene:
- The S. typhimurium histidine (his) and the E. coli tryptophan (trp) reversion system measures his-/his+ and trp-/trp+ reversions, respectively. The S. typhimurium and Escherichia coli strains are constructed to differentiate between base pair (TA1535, TA100, WP2 uvrA pKM101, and WP2 pKM101) and frameshift (TA1537, TA98) mutations.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- other: tryptophan biosynthesis, DNA repair process
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/ß-naphthoflavone induced rat liver S9 was used as the metabolic activation system. The S9 was prepared from 8 – 12 w old male Wistar rats (Hsd Cpb: WU; weight approx. 220 – 320 g, Harlan Laboratories B. V., 5960 AD Horst, The Netherlands).
- Test concentrations with justification for top dose:
- In the pre-experiment the concentration range of the test substance was 3 - 5000 µg/plate. The pre-experiment is reported as experiment I as at least five concentrations were analysable. Since toxic effects were solely observed at high concentrations, 5000 µg/plate was also chosen as maximal concentration of the second experiment.
The concentration range included two logarithmic decades. The following concentrations were tested in experiment II:
3, 10, 33, 100, 333, 1000, 2500, and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (purity 99 %)
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubilisation properties and its relative non-toxicity to the bacteria
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (4-NOPD), 2-aminoanthracene (2-AA)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: direct plate incorporation and pre-incubation method
DURATION
- Preincubation period: 60 minutes
For the pre-incubation method 100 µL test solution (solvent or reference mutagen solution (positive control)), 500 µL S9 mix / S9 mix substitution buffer (7 parts of the 100 mM sodium-ortho-phosphate-buffer pH 7.4 with 3 parts of KCl solution 0.15 M) and 100 µL bacteria suspension were mixed in a test tube and incubated at 37 °C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45 °C) was added to each tube. The mixture was poured on selective agar plates. After solidification the plates were incubated upside down for 72 hours at 37°C in the dark, plates were then stored at 4°C until counted.
- Exposure duration: 60 minutes (pre-exposure) + 72 hours (exposure)
- Expression time (cells in growth medium): in the pre-culture 10^8 to 10^9 cells/mL
- Selection time (if incubation with a selection agent): not applicable
- Fixation time (start of exposure up to fixation or harvest of cells): not applicable
SELECTION AGENT (mutation assays): not applicable
SPINDLE INHIBITOR (cytogenetic assays): not applicable
STAIN (for cytogenetic assays): not applicable
NUMBER OF REPLICATIONS: 3
NUMBER OF CELLS EVALUATED: number of revertant colonies
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
OTHER EXAMINATIONS:
- Determination of polyploidy: not applicable
- Determination of endoreplication: not applicable - Evaluation criteria:
- Acceptability of the assay
The Salmonella typhimurium and Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria:
- regular background growth in the negative and solvent control
- the spontaneous reversion rates in the negative and solvent control are in the range of the historical data
- the positive control substances should produce a significant increase in mutant colony frequencies
- a minimum of five analysable concentrations should be present with at least four showing no signs of toxic effects, evident as a reduction in the number of revertants below an induction factor of 0.5.
Evaluation of results
A test substance is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice the colony count of the corresponding solvent control is observed.
A concentration-dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A concentration-dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no
- Effects of osmolality: no
- Evaporation from medium: no
- Water solubility: DMSO was used as solvent.
- Precipitation: The test substance precipitated in the overlay agar in the test tubes from 1000 to 5000 µg/plate with and without S9 mix in both experiments. Precipitation of the test substance in the overlay agar was also observed on the incubated agar plates from 1000 to 5000 µg/plate in experiment I and from 333 to 5000 µg/plate in experiment II. The undissolved particles had no influence on the data recording.
- Other confounding effects: no
RANGE-FINDING/SCREENING STUDIES:
To evaluate the cytotoxicity of the test substance a pre-experiment was performed with all strains. Eight concentrations were tested for cytotoxicity and mutation induction each with three replicate plates. The experimental conditions in this pre-experiment were the same as described below for experiment I (plate incorporation test).
Cytotoxicity of the test substance results in a reduction in the number of spontaneous revertants (below a factor of 0.5) or a clearing of the bacterial background lawn.
The pre-experiment is reported as the main experiment I since the criteria mentioned under Acceptability of the assay were met.
COMPARISON WITH HISTORICAL CONTROL DATA:
The laboratory historical control range was not quite reached in the untreated control of strain WP2 uvrA pKM101 with S9 mix in experiment I. Since this deviation is rather small, this effect is judged to be based upon statistical fluctuations and has no detrimental impact on the outcome of the study.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Reduced background growth was observed at the following concentrations (µg/plate):
TA 1535: Experiment I (without S9 mix): 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
TA 1537: Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 1000 - 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
TA 98: Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
TA 100: : Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 1000 - 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
WP2 pKM101: : Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
WP2 uvrA pKM101: : Experiment I (without S9 mix): 2500, 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment II (with S9 mix): 333 - 5000
Toxic effects, evident as a reduction in the number of revertants (below an induction factor of 0.5), were observed at the following concentrations (µg/plate):
TA 1535: Experiment I (without S9 mix): / --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 5000 --- Experiment I (with S9 mix): 2500, 5000
TA 1537: Experiment I (without S9 mix): 5000 --- Experiment I (with S9 mix): 1000 - 5000 --- Experiment II (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 333 - 5000
TA 98: Experiment I (without S9 mix): 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 333 - 5000
TA 100: Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 1000 - 5000 --- Experiment II (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 333 - 5000
WP2 pKM101: Experiment I (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 333 - 5000 --- Experiment I (with S9 mix): 333 - 5000
WP2 uvrA pKM101: Experiment I (without S9 mix): 2500, 5000 --- Experiment I (with S9 mix): 2500, 5000 --- Experiment II (without S9 mix): 1000 - 5000 --- Experiment I (with S9 mix): 333 - 5000
/ = no toxic effects observed - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1 Summary of Results Pre-Experiment/Experiment I
Metabolic Activation | Test group | Concentration (per plate) | Revertant Colony Counts (Mean ±SD) | |||||
TA 1535 | TA 1537 | TA 98 | TA 100 | WP2 pKM101 | WP2 uvrA pKM101 | |||
Without Activation | DMSO | --- | 16 ± 1 | 14 ± 6 | 22 ± 4 | 91 ± 3 | 228 ± 24 | 327 ± 30 |
Untreated | --- | 11 ± 2 | 13 ± 2 | 26 ± 6 | 100 ± 15 | 249 ± 12 | 373 ± 1 | |
test item | 3 µg | 13 ± 4 | 9 ± 1 | 20 ± 3 | 91 ± 9 | 231 ± 23 | 331 ± 29 | |
10 µg | 16 ± 3 | 12 ± 2 | 23 ± 7 | 85 ± 10 | 209 ± 16 | 334 ± 46 | ||
33 µg | 18 ± 1 | 10 ± 2 | 19 ± 7 | 91 ± 5 | 190 ± 18 | 294 ± 37 | ||
100 µg | 19 ± 5 | 14 ± 1 | 25 ± 1 | 72 ± 5 | 224 ± 24 | 312 ± 42 | ||
333 µg | 14 ± 3 | 12 ± 6 | 23 ± 3 | 54 ± 17 | 174 ± 26 | 311 ± 19 | ||
1000 µg | 20 ± 3P | 12 ± 4P R | 16 ± 1P R | 31 ± 6P M R | 61 ± 4P R | 205 ± 41P | ||
2500 µg | 14 ± 3P M | 6 ± 3P R M | 11 ± 3P M R | 24 ± 1P M R | 33 ± 4P M R | 93 ± 9P M R | ||
5000 µg | 9 ± 2P M R | 5 ± 2P R M | 4 ± 1P M R | 16 ± 4P M R | 26 ± 3P M R | 58 ± 12P M R | ||
NaN3 | 10 µg | 2919 ± 285 | --- | --- | 2303 ± 99 | --- | --- | |
4-NOPD | 10 µg | --- | --- | 388 ± 12 | --- | --- | --- | |
4-NOPD | 50 µg | --- | 58 ± 5 | --- | --- | --- | --- | |
MMS | 2.0 µL | --- | --- | --- | --- | 3663 ± 93 | 4303 ± 35 | |
With Activation | DMSO | --- | 15 ± 3 | 22 ± 6 | 32 ± 3 | 100 ± 8 | 217 ± 2 | 366 ± 5 |
Untreated | --- | 16 ± 2 | 20 ± 6 | 35 ± 2 | 116 ± 16 | 269 ± 35 | 373 ± 43 | |
test item | 3 µg | 16 ± 4 | 25 ± 4 | 33 ± 2 | 101 ± 14 | 243 ± 19 | 349 ± 14 | |
10 µg | 13 ± 1 | 17 ± 2 | 34 ± 7 | 105 ± 6 | 192 ± 11 | 316 ± 28 | ||
33 µg | 15 ± 6 | 17 ± 3 | 35 ± 8 | 114 ± 12 | 201 ± 15 | 295 ± 21 | ||
100 µg | 17 ± 1 | 14 ± 7 | 34 ± 4 | 103 ± 8 | 203 ± 58 | 304 ± 8 | ||
333 µg | 14 ± 1 | 20 ± 5 | 30 ± 7 | 83 ± 16 | 192 ± 19 | 310 ± 58 | ||
1000 µg | 11 ± 1P | 9 ± 2P M R | 23 ± 6P | 42 ± 6P M R | 104 ± 17P | 212 ± 21P | ||
2500 µg | 3 ± 1P M R | 5 ± 2P M R | 8 ± 2P M R | 16 ± 3P M R | 24 ± 3P M R | 98 ± 16P M R | ||
5000 µg | 2 ± 1P M R | 1 ± 1P M R | 1 ± 1P M R | 0 ± 1P M R | 4 ± 2P M R | 12 ± 2P M R | ||
2-AA | 2.5 µg | 498 ± 40 | 349 ± 36 | 1852 ± 77 | 2408 ± 268 | --- | --- | |
2-AA | 10.0 µg | --- | --- | --- | --- | 3552 ± 129 | 1822 ± 155 |
NaN3. sodium azide
2-AA: 2-aminoanthracene
4-NOPD: 4-nitro-o-phenylene-diamine
MMS: methyl methane sulfonate
P: Precipitate
M: Manual count
R: Reduced background growth
Table 2 Summary of Results Experiment II
Metabolic Activation | Test group | Concentration (per plate) | Revertant Colony Counts (Mean ±SD) | |||||
TA 1535 | TA 1537 | TA 98 | TA 100 | WP2 pKM101 | WP2 uvrA pKM101 | |||
Without Activation | DMSO | --- | 16 ± 5 | 9 ± 2 | 27 ± 4 | 96 ± 17 | 243 ± 2 | 407 ± 11 |
Untreated | --- | 17 ± 4 | 10 ± 5 | 32 ± 1 | 105 ± 7 | 276 ± 27 | 419 ± 6 | |
test item | 3 µg | 15 ± 1 | 9 ± 3 | 19 ± 5 | 93 ± 16 | 247 ± 12 | 412 ± 23 | |
10 µg | 13 ± 6 | 8 ± 1 | 17 ± 2 | 83 ± 11 | 232 ± 17 | 413 ± 10 | ||
33 µg | 14 ± 2 | 11 ± 1 | 16 ± 3 | 91 ± 10 | 235 ± 11 | 460 ± 10 | ||
100 µg | 19 ± 5 | 6 ± 2 | 21 ± 2 | 72 ± 14 | 112 ± 31 | 259 ± 15 | ||
333 µg | 16 ± 3P R | 6 ± 1P R | 17 ± 4P R | 59 ± 10P R | 68 ± 7P R | 207 ± 16P R | ||
1000 µg | 14 ± 5P M R | 3 ± 1P M R | 9 ± 2P M R | 13 ± 5P M R | 32 ± 7P M R | 112 ± 6P M R | ||
2500 µg | 8 ± 3P M R | 3 ± 2P M R | 2 ± 1P M R | 21 ± 1P M R | 15 ± 4P M R | 47 ± 5P M R | ||
5000 µg | 3 ± 2P M R | 0 ± 0P M R | 0 ± 0P M R | 0 ± 0P M R | 8 ± 4P M R | 17 ± 4P M R | ||
NaN3 | 10 µg | 2706 ± 139 | --- | --- | 2241 ± 83 | --- | --- | |
4-NOPD | 10 µg | --- | --- | 341 ± 25 | --- | --- | --- | |
4-NOPD | 50 µg | --- | 75 ± 16 | --- | --- | --- | --- | |
MMS | 2.0 µL | --- | --- | --- | --- | 3107 ± 175 | 2908 ± 14 | |
With Activation | DMSO | --- | 11 ± 4 | 15 ± 1 | 36 ± 2 | 104 ± 12 | 266 ± 23 | 453 ± 3 |
Untreated | --- | 10 ± 3 | 17 ± 4 | 31 ± 9 | 131 ± 5 | 314 ± 22 | 449 ± 1 | |
test item | 3 µg | 7 ± 4 | 19 ± 7 | 33 ± 4 | 106 ± 13 | 262 ± 5 | 431 ± 49 | |
10 µg | 12 ± 2 | 11 ± 3 | 29 ± 5 | 115 ± 1 | 252 ± 5 | 444 ± 7 | ||
33 µg | 14 ± 2 | 10 ± 4 | 26 ± 3 | 95 ± 18 | 267 ± 21 | 486 ± 6 | ||
100 µg | 15 ± 6 | 13 ± 5 | 37 ± 8 | 105 ± 3 | 256 ± 19 | 424 ± 28 | ||
333 µg | 8 ± 5P M R | 3 ± 5P M R | 16 ± 5P M R | 23 ± 6P M R | 32 ± 9P M R | 78 ± 9P M R | ||
1000 µg | 8 ± 4P M R | 0 ± 1P M R | 4 ± 1P M R | 3 ± 2P M R | 25 ± 6P M R | 50 ± 11P M R | ||
2500 µg | 2 ± 1P M R | 4 ± 1P M R | 0 ± 0P M R | 0 ± 0P M R | 2 ± 1P M R | 21 ± 2P M R | ||
5000 µg | 1 ± 1P M R | 0 ± 0P M R | 0 ± 0P M R | 0 ± 0P M R | 0 ± 1P M R | 0 ± 0P M R | ||
2-AA | 2.5 µg | 408 ± 5 | 327 ± 12 | 2406 ± 113 | 2974 ± 707 | --- | --- | |
2-AA | 10.0 µg | --- | --- | --- | --- | 2072 ± 44 | 2205 ± 126 |
NaN3. sodium azide
2-AA: 2-aminoanthracene
4-NOPD: 4-nitro-o-phenylene-diamine
MMS: methyl methane sulfonate
P: Precipitate
R: reduced background growth
M: Manual count
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
During the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the substance is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay. - Executive summary:
This study was performed to investigate the potential of the test item to induce gene mutations in the plate incorporation test and the pre-incubation test using the Salmonella typhimurium strains and the Escherichia coli strains. The plates incubated with the test substance showed reduced background growth at higher concentrations with all strains used. Cytotoxic effects were observed in all strains at higher concentrations with the exception of strain TA 1535 in the first experiment without metabolic activation. No increase in revertant colony numbers of any of the six tester strains was observed. There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies. The test item is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.